UNICK FIX-A-FORM AND PRINTERS | AARTI DRUGS | UNICK FIX-A-FORM AND PRINTERS/ AARTI DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | 25.7 | 108.9% | View Chart |
P/BV | x | 1.1 | 3.9 | 29.6% | View Chart |
Dividend Yield | % | 0.0 | 0.2 | - |
UNICK FIX-A-FORM AND PRINTERS AARTI DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
AARTI DRUGS Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ AARTI DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 532 | 11.1% | |
Low | Rs | 32 | 311 | 10.1% | |
Sales per share (Unadj.) | Rs | 120.5 | 293.3 | 41.1% | |
Earnings per share (Unadj.) | Rs | 4.1 | 18.0 | 22.7% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 23.4 | 47.9% | |
Dividends per share (Unadj.) | Rs | 0 | 1.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.2 | 0.0% | |
Book value per share (Unadj.) | Rs | 53.9 | 128.8 | 41.9% | |
Shares outstanding (eoy) | m | 5.49 | 92.60 | 5.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 1.4 | 26.1% | |
Avg P/E ratio | x | 11.1 | 23.4 | 47.3% | |
P/CF ratio (eoy) | x | 4.0 | 18.0 | 22.4% | |
Price / Book Value ratio | x | 0.8 | 3.3 | 25.7% | |
Dividend payout | % | 0 | 5.6 | 0.0% | |
Avg Mkt Cap | Rs m | 248 | 39,003 | 0.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 804 | 11.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 27,161 | 2.4% | |
Other income | Rs m | 5 | 22 | 23.3% | |
Total revenues | Rs m | 667 | 27,182 | 2.5% | |
Gross profit | Rs m | 88 | 3,095 | 2.8% | |
Depreciation | Rs m | 39 | 503 | 7.8% | |
Interest | Rs m | 24 | 371 | 6.4% | |
Profit before tax | Rs m | 30 | 2,242 | 1.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 578 | 1.3% | |
Profit after tax | Rs m | 22 | 1,664 | 1.3% | |
Gross profit margin | % | 13.3 | 11.4 | 116.4% | |
Effective tax rate | % | 25.0 | 25.8 | 96.9% | |
Net profit margin | % | 3.4 | 6.1 | 55.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 14,923 | 2.0% | |
Current liabilities | Rs m | 287 | 9,330 | 3.1% | |
Net working cap to sales | % | 2.1 | 20.6 | 10.3% | |
Current ratio | x | 1.0 | 1.6 | 65.6% | |
Inventory Days | Days | 4 | 6 | 67.8% | |
Debtors Days | Days | 72,349,839 | 1,162 | 6,225,120.9% | |
Net fixed assets | Rs m | 402 | 9,290 | 4.3% | |
Share capital | Rs m | 55 | 926 | 5.9% | |
"Free" reserves | Rs m | 241 | 10,998 | 2.2% | |
Net worth | Rs m | 296 | 11,924 | 2.5% | |
Long term debt | Rs m | 89 | 2,047 | 4.3% | |
Total assets | Rs m | 705 | 24,214 | 2.9% | |
Interest coverage | x | 2.3 | 7.0 | 32.0% | |
Debt to equity ratio | x | 0.3 | 0.2 | 174.7% | |
Sales to assets ratio | x | 0.9 | 1.1 | 83.6% | |
Return on assets | % | 6.6 | 8.4 | 78.0% | |
Return on equity | % | 7.6 | 14.0 | 54.3% | |
Return on capital | % | 14.0 | 18.7 | 74.6% | |
Exports to sales | % | 0 | 31.4 | 0.0% | |
Imports to sales | % | 0 | 33.4 | 0.0% | |
Exports (fob) | Rs m | NA | 8,536 | 0.0% | |
Imports (cif) | Rs m | NA | 9,082 | 0.0% | |
Fx inflow | Rs m | 0 | 8,536 | 0.0% | |
Fx outflow | Rs m | 0 | 9,352 | 0.0% | |
Net fx | Rs m | 0 | -816 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 1,342 | 3.3% | |
From Investments | Rs m | -27 | -1,640 | 1.6% | |
From Financial Activity | Rs m | -16 | 165 | -9.9% | |
Net Cashflow | Rs m | 0 | -132 | -0.3% |
Indian Promoters | % | 71.6 | 57.1 | 125.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 8.6 | 5.3% | |
FIIs | % | 0.0 | 2.6 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 42.9 | 66.3% | |
Shareholders | 1,622 | 157,547 | 1.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | AARTI DRUGS | S&P BSE TECK |
---|---|---|---|
1-Day | 4.56% | 0.59% | -0.26% |
1-Month | 21.23% | 13.61% | -0.74% |
1-Year | 56.84% | 21.62% | 29.95% |
3-Year CAGR | 31.01% | -11.15% | 10.57% |
5-Year CAGR | 20.58% | 26.46% | 15.11% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the AARTI DRUGS share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of AARTI DRUGS the stake stands at 57.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of AARTI DRUGS.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
AARTI DRUGS paid Rs 1.0, and its dividend payout ratio stood at 5.6%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of AARTI DRUGS.
For a sector overview, read our media sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.